Low-volume resuscitation from traumatic hemorrhagic shock with Na+/H+ exchanger inhibitor

Dongmei Wu, Hui Dai, Jaqueline Arias, Loren Latta, William M. Abraham

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective: To evaluate the use of a Na/H exchanger (NHE-1) inhibitor as a cardioprotective adjunct therapy to low-volume resuscitation in two different rat models of traumatic hemorrhagic shock. Design: Experimental, prospective study. Setting: Medical center research laboratory. Subjects: Sprague Dawley male rats. Interventions: Series 1: femur fracture was induced in anesthetized rats, followed by pressure-controlled hemorrhage (40 mm Hg for 20 minutes) and resuscitation. Groups: 1) no therapy; 2) 15 mL/kg hetastarch; and 3) 3 mg/kg benzamide, N-(aminoiminomethyl)-4-[4-(2-furanylcarbonyl)-1-piperazinyl]-3- (methylsulfonyl), methanesulfonate (BIIB513) (NHE-1 inhibitor) + 15 mL/kg hetastarch infusion over 40 minutes. The experiment was terminated at 6 hours after resuscitation. Series 2: the rats received laparotomy and closure under anesthesia and subsequently remained conscious for the rest of the study. The rats were subjected to volume-controlled hemorrhage (2.5 mL/100 g) followed by resuscitation as described in series 1. The experiment was terminated at 24 hours after resuscitation. Measurements and main results: Series 1: all animals in the no-therapy group died within 2 hours. Compared with hetastarch infusion alone, the addition of NHE-1 inhibitor improved the hemodynamic response to fluid resuscitation, increased blood oxygen content, prevented metabolic acidosis, and improved 6-hour survival (42% in hetastarch group vs. 80% in BIIB513 + hetastarch group). NHE-1 inhibition also resulted in reduced plasma levels of tumor necrosis factor-α, intercellular adhesion molecule-1, and C-reactive protein, and attenuated neutrophil infiltration in the liver. Series 2: all animals in the no-therapy group died within 4 hours after hemorrhage. Compared with hetastarch infusion alone, the addition of BIIB513 improved 24-hour survival (44% in hetastarch group vs. 78% in BIIB513 + hetastarch group). NHE-1 inhibition also reduced plasma levels alanine aminotransferase at 24 hours after resuscitation. Conclusions: NHE-1 inhibition facilitated the hemodynamic response to fluid resuscitation, attenuated tissue inflammatory injury, and organ dysfunction, but most importantly improved survival.

Original languageEnglish
Pages (from-to)1994-1999
Number of pages6
JournalCritical Care Medicine
Volume37
Issue number6
DOIs
StatePublished - May 1 2009
Externally publishedYes

Fingerprint

Hydroxyethyl Starch Derivatives
Traumatic Shock
Sodium-Hydrogen Antiporter
Hemorrhagic Shock
Resuscitation
Hemorrhage
Group Psychotherapy
Hemodynamics
Neutrophil Infiltration
Intercellular Adhesion Molecule-1
Acidosis
Alanine Transaminase
C-Reactive Protein
Femur
Laparotomy
Sprague Dawley Rats
Biomedical Research
Research Design
Anesthesia
Tumor Necrosis Factor-alpha

Keywords

  • Low volume resuscitation
  • Metabolic acidosis
  • Na /H exchanger
  • Organ function
  • Proinflammatory mediator
  • Traumatic hemorrhagic shock

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Low-volume resuscitation from traumatic hemorrhagic shock with Na+/H+ exchanger inhibitor. / Wu, Dongmei; Dai, Hui; Arias, Jaqueline; Latta, Loren; Abraham, William M.

In: Critical Care Medicine, Vol. 37, No. 6, 01.05.2009, p. 1994-1999.

Research output: Contribution to journalArticle

Wu, Dongmei ; Dai, Hui ; Arias, Jaqueline ; Latta, Loren ; Abraham, William M. / Low-volume resuscitation from traumatic hemorrhagic shock with Na+/H+ exchanger inhibitor. In: Critical Care Medicine. 2009 ; Vol. 37, No. 6. pp. 1994-1999.
@article{26197dced24a4d3db38dcc453a0594e6,
title = "Low-volume resuscitation from traumatic hemorrhagic shock with Na+/H+ exchanger inhibitor",
abstract = "Objective: To evaluate the use of a Na/H exchanger (NHE-1) inhibitor as a cardioprotective adjunct therapy to low-volume resuscitation in two different rat models of traumatic hemorrhagic shock. Design: Experimental, prospective study. Setting: Medical center research laboratory. Subjects: Sprague Dawley male rats. Interventions: Series 1: femur fracture was induced in anesthetized rats, followed by pressure-controlled hemorrhage (40 mm Hg for 20 minutes) and resuscitation. Groups: 1) no therapy; 2) 15 mL/kg hetastarch; and 3) 3 mg/kg benzamide, N-(aminoiminomethyl)-4-[4-(2-furanylcarbonyl)-1-piperazinyl]-3- (methylsulfonyl), methanesulfonate (BIIB513) (NHE-1 inhibitor) + 15 mL/kg hetastarch infusion over 40 minutes. The experiment was terminated at 6 hours after resuscitation. Series 2: the rats received laparotomy and closure under anesthesia and subsequently remained conscious for the rest of the study. The rats were subjected to volume-controlled hemorrhage (2.5 mL/100 g) followed by resuscitation as described in series 1. The experiment was terminated at 24 hours after resuscitation. Measurements and main results: Series 1: all animals in the no-therapy group died within 2 hours. Compared with hetastarch infusion alone, the addition of NHE-1 inhibitor improved the hemodynamic response to fluid resuscitation, increased blood oxygen content, prevented metabolic acidosis, and improved 6-hour survival (42{\%} in hetastarch group vs. 80{\%} in BIIB513 + hetastarch group). NHE-1 inhibition also resulted in reduced plasma levels of tumor necrosis factor-α, intercellular adhesion molecule-1, and C-reactive protein, and attenuated neutrophil infiltration in the liver. Series 2: all animals in the no-therapy group died within 4 hours after hemorrhage. Compared with hetastarch infusion alone, the addition of BIIB513 improved 24-hour survival (44{\%} in hetastarch group vs. 78{\%} in BIIB513 + hetastarch group). NHE-1 inhibition also reduced plasma levels alanine aminotransferase at 24 hours after resuscitation. Conclusions: NHE-1 inhibition facilitated the hemodynamic response to fluid resuscitation, attenuated tissue inflammatory injury, and organ dysfunction, but most importantly improved survival.",
keywords = "Low volume resuscitation, Metabolic acidosis, Na /H exchanger, Organ function, Proinflammatory mediator, Traumatic hemorrhagic shock",
author = "Dongmei Wu and Hui Dai and Jaqueline Arias and Loren Latta and Abraham, {William M.}",
year = "2009",
month = "5",
day = "1",
doi = "10.1097/CCM.0b013e3181a0052e",
language = "English",
volume = "37",
pages = "1994--1999",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Low-volume resuscitation from traumatic hemorrhagic shock with Na+/H+ exchanger inhibitor

AU - Wu, Dongmei

AU - Dai, Hui

AU - Arias, Jaqueline

AU - Latta, Loren

AU - Abraham, William M.

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Objective: To evaluate the use of a Na/H exchanger (NHE-1) inhibitor as a cardioprotective adjunct therapy to low-volume resuscitation in two different rat models of traumatic hemorrhagic shock. Design: Experimental, prospective study. Setting: Medical center research laboratory. Subjects: Sprague Dawley male rats. Interventions: Series 1: femur fracture was induced in anesthetized rats, followed by pressure-controlled hemorrhage (40 mm Hg for 20 minutes) and resuscitation. Groups: 1) no therapy; 2) 15 mL/kg hetastarch; and 3) 3 mg/kg benzamide, N-(aminoiminomethyl)-4-[4-(2-furanylcarbonyl)-1-piperazinyl]-3- (methylsulfonyl), methanesulfonate (BIIB513) (NHE-1 inhibitor) + 15 mL/kg hetastarch infusion over 40 minutes. The experiment was terminated at 6 hours after resuscitation. Series 2: the rats received laparotomy and closure under anesthesia and subsequently remained conscious for the rest of the study. The rats were subjected to volume-controlled hemorrhage (2.5 mL/100 g) followed by resuscitation as described in series 1. The experiment was terminated at 24 hours after resuscitation. Measurements and main results: Series 1: all animals in the no-therapy group died within 2 hours. Compared with hetastarch infusion alone, the addition of NHE-1 inhibitor improved the hemodynamic response to fluid resuscitation, increased blood oxygen content, prevented metabolic acidosis, and improved 6-hour survival (42% in hetastarch group vs. 80% in BIIB513 + hetastarch group). NHE-1 inhibition also resulted in reduced plasma levels of tumor necrosis factor-α, intercellular adhesion molecule-1, and C-reactive protein, and attenuated neutrophil infiltration in the liver. Series 2: all animals in the no-therapy group died within 4 hours after hemorrhage. Compared with hetastarch infusion alone, the addition of BIIB513 improved 24-hour survival (44% in hetastarch group vs. 78% in BIIB513 + hetastarch group). NHE-1 inhibition also reduced plasma levels alanine aminotransferase at 24 hours after resuscitation. Conclusions: NHE-1 inhibition facilitated the hemodynamic response to fluid resuscitation, attenuated tissue inflammatory injury, and organ dysfunction, but most importantly improved survival.

AB - Objective: To evaluate the use of a Na/H exchanger (NHE-1) inhibitor as a cardioprotective adjunct therapy to low-volume resuscitation in two different rat models of traumatic hemorrhagic shock. Design: Experimental, prospective study. Setting: Medical center research laboratory. Subjects: Sprague Dawley male rats. Interventions: Series 1: femur fracture was induced in anesthetized rats, followed by pressure-controlled hemorrhage (40 mm Hg for 20 minutes) and resuscitation. Groups: 1) no therapy; 2) 15 mL/kg hetastarch; and 3) 3 mg/kg benzamide, N-(aminoiminomethyl)-4-[4-(2-furanylcarbonyl)-1-piperazinyl]-3- (methylsulfonyl), methanesulfonate (BIIB513) (NHE-1 inhibitor) + 15 mL/kg hetastarch infusion over 40 minutes. The experiment was terminated at 6 hours after resuscitation. Series 2: the rats received laparotomy and closure under anesthesia and subsequently remained conscious for the rest of the study. The rats were subjected to volume-controlled hemorrhage (2.5 mL/100 g) followed by resuscitation as described in series 1. The experiment was terminated at 24 hours after resuscitation. Measurements and main results: Series 1: all animals in the no-therapy group died within 2 hours. Compared with hetastarch infusion alone, the addition of NHE-1 inhibitor improved the hemodynamic response to fluid resuscitation, increased blood oxygen content, prevented metabolic acidosis, and improved 6-hour survival (42% in hetastarch group vs. 80% in BIIB513 + hetastarch group). NHE-1 inhibition also resulted in reduced plasma levels of tumor necrosis factor-α, intercellular adhesion molecule-1, and C-reactive protein, and attenuated neutrophil infiltration in the liver. Series 2: all animals in the no-therapy group died within 4 hours after hemorrhage. Compared with hetastarch infusion alone, the addition of BIIB513 improved 24-hour survival (44% in hetastarch group vs. 78% in BIIB513 + hetastarch group). NHE-1 inhibition also reduced plasma levels alanine aminotransferase at 24 hours after resuscitation. Conclusions: NHE-1 inhibition facilitated the hemodynamic response to fluid resuscitation, attenuated tissue inflammatory injury, and organ dysfunction, but most importantly improved survival.

KW - Low volume resuscitation

KW - Metabolic acidosis

KW - Na /H exchanger

KW - Organ function

KW - Proinflammatory mediator

KW - Traumatic hemorrhagic shock

UR - http://www.scopus.com/inward/record.url?scp=66449112271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66449112271&partnerID=8YFLogxK

U2 - 10.1097/CCM.0b013e3181a0052e

DO - 10.1097/CCM.0b013e3181a0052e

M3 - Article

C2 - 19384202

AN - SCOPUS:66449112271

VL - 37

SP - 1994

EP - 1999

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 6

ER -